The drug development software and services provider reported adjusted earnings per share of $0.13 for the quarter ended November 30, 2025, missing the analyst estimate of $0.19 by $0.06. Revenue came ...

As a trader, operating without the Commitments of Traders (COT) report during the recent 43-day govt. shutdown felt like ...

The Japanese Yen (JPY) extends its steady intraday ascent against a broadly weaker US Dollar (USD) through the early European ...

XRP price and Solana price enter January 2026 from very different recovery structures despite both rebounding from prolonged ...

In contrast, Hershey was upgraded to Overweight, with Piper Sandler citing significant earnings flexibility as cocoa ...

Accumulation is reflected clearly in price action. Because Iota [IOTA] has gained 12% in the past 24 hours, extending its ...

The dollar, which would normally expect a safe-haven bid, is back on the ropes this morning, crude prices are almost exactly ...

Stock markets in the U.S. (.SPX), Japan (.N225) and Europe (.STOXX) should rally this year, but will struggle to match 2025's ...

The investment case for Core Scientific has become a study in contrasts, with a starkly negative rating from one prominent research firm clashing against a generally optimistic analyst consensus. This ...

The EUR/USD pair attracts heavy selling for the second straight day and dives to a nearly four-week trough, around the 1.1670 ...

GBP/USD in 2026 sees limited upside, with a weaker dollar helping early gains while UK growth, BoE cuts, and fiscal strain ...

Shares of financial software provider BlackLine received a vote of confidence today from Rosenblatt Securities. The investment bank initiated coverage with a “Buy” rating and set a price target of $65 ...